Global Molybdenum-99 Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Isotopic Application;
Gamma Camera and SPECT.By End User;
Hospitals and Diagnostic Centers.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Molybdenum-99 Market (USD Million), 2021 - 2031
In the year 2024, the Global Molybdenum-99 Market was valued at USD 546.68 million. The size of this market is expected to increase to USD 716.97 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.0%.
The Global Molybdenum-99 Market plays a critical role in nuclear medicine, serving as a key radioisotope for medical imaging procedures worldwide. Molybdenum-99 (Mo-99) is the parent isotope of technetium-99m (Tc-99m), which is widely used in diagnostic imaging for procedures such as single-photon emission computed tomography (SPECT) and myocardial perfusion imaging. Tc-99m is highly valued for its favorable imaging characteristics, including its short half-life and ability to emit gamma rays suitable for medical imaging. The production and distribution of Mo-99 are thus essential for ensuring a stable and reliable supply of Tc-99m to healthcare facilities globally.
The Mo-99 market is characterized by a complex supply chain involving nuclear reactors or cyclotrons for production, followed by processing and distribution networks to deliver the isotope to end-users. Nuclear reactors are the primary source of Mo-99 production, utilizing the neutron irradiation of molybdenum-98 targets to produce Mo-99. The reliability of reactor-based production has been a concern due to reactor shutdowns, maintenance issues, and geopolitical factors affecting the availability of enriched uranium targets. In recent years, efforts have been made to diversify Mo-99 production methods, including the development of alternative production technologies such as cyclotron-based production, which offers potential advantages in terms of flexibility and reliability.
The global demand for Mo-99 continues to grow steadily, driven by the increasing prevalence of cardiovascular diseases, cancer, and other medical conditions requiring diagnostic imaging. The expanding applications of nuclear medicine, coupled with advancements in imaging technology and radiopharmaceutical development, further contribute to the rising demand for Mo-99. Challenges persist in ensuring a sustainable supply of Mo-99 to meet the growing demand, prompting ongoing investments in production infrastructure, supply chain optimization, and technological innovation. Addressing these challenges is crucial for ensuring the availability of essential diagnostic tools and advancing the field of nuclear medicine for improved patient care and disease management.
Global Molybdenum-99 Market Recent Developments
-
In January 2024, Chinese researchers developed a method to produce the medicinal isotope molybdenum-99 (Mo-99) using an electron accelerator system
-
In January 2024, the OECD Nuclear Energy Agency (NEA) and the Canadian Nuclear Isotope Council (CNIC) announced their intention to collaborate to secure a supply of medicinal radioisotopes
Segment Analysis
Production methods for Mo-99 primarily include nuclear reactor-based production and cyclotron-based production. Nuclear reactor-based production traditionally dominates the market, as it accounts for the majority of global Mo-99 supply. This method involves the irradiation of molybdenum-98 targets in nuclear reactors, followed by the extraction and processing of Mo-99. Concerns regarding reactor reliability and supply disruptions have prompted interest in alternative production methods, such as cyclotron-based production. Cyclotron-based production offers potential advantages in terms of flexibility and scalability, as it does not rely on nuclear reactors and can be implemented in smaller facilities, contributing to the diversification of the Mo-99 supply chain.
End-use segmentation of the Mo-99 market includes diagnostic imaging, therapeutic applications, and research. Diagnostic imaging represents the largest segment, driven by the widespread use of technetium-99m (Tc-99m), the daughter isotope of Mo-99, in nuclear medicine procedures such as SPECT imaging and bone scans. Tc-99m is highly valued for its favorable imaging characteristics and is indispensable for a wide range of diagnostic applications across various medical specialties. Therapeutic applications of Mo-99, such as targeted radionuclide therapy, are also gaining traction, particularly in the treatment of certain types of cancer. Mo-99 is utilized in research settings for radiopharmaceutical development, preclinical imaging studies, and other scientific investigations, contributing to the overall demand for this radioisotope.
The Mo-99 market is distributed across regions such as North America, Europe, Asia-Pacific, and the rest of the world. North America accounts for a significant share of the market, driven by the presence of established nuclear medicine infrastructure, a robust regulatory framework, and high demand for diagnostic imaging procedures. Europe is another key market, characterized by advanced healthcare systems, extensive clinical research activities, and strategic initiatives aimed at ensuring a reliable supply of Mo-99. The Asia-Pacific region is witnessing rapid growth in the Mo-99 market, fueled by expanding healthcare infrastructure, increasing adoption of nuclear medicine techniques, and rising investments in medical imaging technology. The rest of the world also contributes to the global Mo-99 market, with emerging markets exhibiting growing demand for nuclear medicine services and diagnostic imaging solutions.
Global Molybdenum-99 Segment Analysis
In this report, the Global Molybdenum-99 Market has been segmented by Isotopic Application, End User and Geography.
Global Molybdenum-99 Market, Segmentation by Isotopic Application
The Global Molybdenum-99 Market has been segmented by Isotopic Application into Gamma Camera and SPECT.
The gamma camera imaging utilizes radiopharmaceuticals, such as technetium-99m (Tc-99m), derived from Mo-99, to visualize the distribution of radioactive tracers within the body. Gamma cameras detect gamma rays emitted by these tracers, enabling the non-invasive assessment of organ function, blood flow, and disease localization. This imaging modality is widely used in clinical practice for a variety of diagnostic purposes, including cardiac imaging, oncology, and neurology, contributing to the significant demand for Mo-99 in gamma camera applications.
SPECT imaging represents another important segment of the Mo-99 market, offering enhanced three-dimensional visualization capabilities compared to traditional gamma camera imaging. SPECT imaging systems utilize gamma-ray detectors positioned around the patient to capture multiple views of the body, allowing for more accurate localization and quantification of radioactive tracers. Technetium-99m, generated from Mo-99, is the most commonly used radiotracer in SPECT imaging due to its favorable imaging characteristics and widespread availability. SPECT imaging is utilized in various medical specialties, including cardiology, oncology, and neurology, for both diagnostic and therapeutic purposes. The growing adoption of SPECT imaging systems in clinical practice and the expanding applications of nuclear medicine contribute to the continued demand for Mo-99 in SPECT isotopic applications.
The segmentation of the Mo-99 market by isotopic application underscores the importance of this radioisotope in advancing diagnostic imaging technologies and improving patient care. Both gamma camera and SPECT imaging techniques rely on the availability of Mo-99-derived radiopharmaceuticals to perform a wide range of diagnostic procedures effectively. The continuous innovation in imaging hardware and software, coupled with ongoing advancements in radiopharmaceutical development, further drive the demand for Mo-99 in gamma camera and SPECT applications. As healthcare providers increasingly rely on nuclear medicine imaging for accurate disease diagnosis and treatment planning, the demand for Mo-99 is expected to remain robust in both gamma camera and SPECT isotopic applications, contributing to the growth of the global Mo-99 market.
Global Molybdenum-99 Market, Segmentation by End User
The Global Molybdenum-99 Market has been segmented by End User into Hospitals and Diagnostic Centers.
The hospitals represent the primary end-users of Molybdenum-99 (Mo-99), leveraging it for various diagnostic procedures and therapeutic treatments. With the increasing prevalence of chronic diseases and the rising demand for accurate diagnostic tools, hospitals account for a significant share of Mo-99 consumption globally. These healthcare facilities rely on Mo-99 for its ability to produce technetium-99m (Tc-99m), a widely used radioisotope in nuclear medicine imaging procedures such as single-photon emission computed tomography (SPECT).
Diagnostic centers also constitute a vital segment in the Mo-99 market, catering to the growing need for specialized imaging services and nuclear medicine procedures. These centers often feature state-of-the-art imaging equipment and specialized personnel dedicated to conducting a wide range of diagnostic tests and therapeutic interventions. By utilizing Mo-99-derived Tc-99m, diagnostic centers offer advanced imaging capabilities for detecting various medical conditions, including cancer, cardiovascular diseases, and neurological disorders. The accessibility and convenience provided by diagnostic centers play a crucial role in promoting early disease detection and personalized treatment options for patients.
Both hospitals and diagnostic centers contribute to the sustained demand for Mo-99, driven by factors such as increasing healthcare expenditure, advancements in medical imaging technologies, and the growing prevalence of chronic diseases worldwide. As healthcare systems continue to evolve and prioritize precision medicine approaches, the demand for Mo-99 and its derived isotopes is expected to rise further. Efforts to ensure a stable supply chain for Mo-99 production and distribution are essential to support the diagnostic and therapeutic needs of healthcare facilities, ultimately enhancing patient care outcomes globally.
Global Molybdenum-99 Market, Segmentation by Geography
In this report, the Global Molybdenum-99 Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Molybdenum-99 Market Share (%), by Geographical Region, 2024
North America holds a significant share of the market, driven by the presence of established healthcare infrastructure, leading research institutions, and a high prevalence of medical conditions requiring diagnostic imaging. The region is home to key players in the nuclear medicine industry and hosts several nuclear reactors dedicated to Mo-99 production. Stringent regulatory standards and quality assurance measures ensure the reliability and safety of Mo-99 supply in North America, contributing to its prominence in the global market.
Europe is another prominent region in the Global Molybdenum-99 Market, characterized by advanced healthcare systems, extensive clinical research activities, and strategic initiatives aimed at ensuring a stable supply of Mo-99. The European market benefits from collaborations between industry stakeholders, research organizations, and regulatory authorities to address challenges related to Mo-99 production, distribution, and quality control. The region's focus on sustainability and innovation drives investments in alternative production methods and supply chain optimization, reinforcing its position as a key player in the global Mo-99 market.
The Asia Pacific region is witnessing rapid growth in the Molybdenum-99 Market, fueled by expanding healthcare infrastructure, increasing adoption of nuclear medicine techniques, and rising investments in medical imaging technology. Countries such as China, Japan, South Korea, and India are at the forefront of this growth, driven by factors such as demographic trends, economic development, and government initiatives to enhance healthcare access and quality. The Asia Pacific market presents opportunities for market players to expand their presence, forge strategic partnerships, and capitalize on the growing demand for Mo-99 and related nuclear medicine services in the region.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Molybdenum-99 Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Medical Imaging
- Nuclear Medicine
-
Technetium-99m : Technetium-99m (Tc-99m) plays a pivotal role in the Global Molybdenum-99 Market, serving as one of the most widely used radioisotopes in nuclear medicine for diagnostic imaging procedures. Tc-99m is derived from the decay of its parent isotope, molybdenum-99 (Mo-99), and possesses ideal characteristics for medical imaging, including a short half-life and the emission of gamma rays suitable for imaging purposes. Due to its favorable properties, Tc-99m is extensively utilized in various diagnostic imaging techniques, such as single-photon emission computed tomography (SPECT) and myocardial perfusion imaging, for the detection and characterization of a wide range of medical conditions. Its versatility, reliability, and safety profile have established Tc-99m as an indispensable tool in nuclear medicine, driving its demand and shaping the dynamics of the Mo-99 market.
The production and distribution of Tc-99m are reliant on a stable and consistent supply of Mo-99, as Mo-99 serves as the primary precursor for Tc-99m. Nuclear reactors are the primary source of Mo-99 production, where molybdenum-98 targets undergo neutron irradiation to produce Mo-99. Subsequently, Mo-99 is extracted and processed to obtain Tc-99m for medical use. The global Mo-99 supply chain, therefore, plays a critical role in ensuring the availability of Tc-99m to healthcare facilities worldwide. Challenges related to Mo-99 production, such as reactor shutdowns, maintenance issues, and supply chain disruptions, can impact the availability of Tc-99m, highlighting the interconnected nature of the Mo-99 and Tc-99m markets.
The demand for Tc-99m continues to grow steadily, driven by factors such as the increasing prevalence of cardiovascular diseases, cancer, and other medical conditions requiring diagnostic imaging, as well as advancements in imaging technology and radiopharmaceutical development. The widespread adoption of Tc-99m-based imaging techniques in clinical practice underscores its importance in disease diagnosis, treatment planning, and patient management. Ongoing efforts to enhance the efficiency, safety, and accessibility of nuclear medicine procedures contribute to the sustained demand for Tc-99m and drive innovation within the Mo-99 market to ensure a reliable supply of this essential radioisotope for medical imaging applications worldwide.
Restraints
- Supply Chain
- Production Challenges
-
Technetium Shortage : The Global Molybdenum-99 Market faces challenges stemming from periodic shortages of its derivative, technetium-99m (Tc-99m), impacting medical imaging and nuclear medicine applications worldwide. Technetium-99m is a crucial radioisotope utilized in various diagnostic procedures, including myocardial perfusion imaging, bone scans, and tumor localization. Shortages of Tc-99m often occur due to disruptions in the supply chain of its parent isotope, Molybdenum-99 (Mo-99), which is primarily produced from nuclear reactors. Issues such as reactor shutdowns, maintenance delays, and unexpected technical failures can lead to interruptions in Mo-99 production, subsequently affecting Tc-99m availability and causing concerns within the healthcare industry.
The shortage of technetium-99m poses significant challenges for hospitals, diagnostic centers, and healthcare providers reliant on nuclear medicine imaging for patient diagnosis and management. Limited access to Tc-99m can result in delayed or canceled diagnostic procedures, impacting patient care and diagnostic accuracy. Healthcare facilities may face increased operational costs and resource allocation challenges as they seek alternative imaging modalities or navigate through supply shortages. The uncertainty surrounding Tc-99m availability underscores the importance of diversifying supply sources and implementing contingency plans to mitigate the impact of future disruptions on medical imaging services.
Addressing the technetium shortage requires collaborative efforts among industry stakeholders, government agencies, and regulatory bodies to ensure a reliable and sustainable supply of Mo-99 and its derivatives. Investments in innovative production technologies, such as non-reactor-based methods and alternative Mo-99 production facilities, can help diversify the supply chain and reduce dependency on nuclear reactors. Enhancing international cooperation and coordination in Mo-99 production and distribution can improve supply chain resilience and minimize the risk of shortages. By proactively addressing supply challenges and implementing robust contingency measures, the global healthcare industry can better meet the diagnostic and therapeutic needs of patients while ensuring the continued advancement of nuclear medicine imaging technologies.
Opportunities
- Technological Innovation
- Supply Chain Optimization
-
Infrastructure Investment : Infrastructure investment plays a crucial role in shaping the Global Molybdenum-99 Market, influencing production capacity, supply chain efficiency, and overall market dynamics. Investments in nuclear reactors and cyclotron facilities are fundamental to increasing Mo-99 production capacity and diversifying supply sources. Nuclear reactors remain the primary production method for Mo-99, requiring substantial capital investment in reactor upgrades, maintenance, and safety measures to ensure reliable and efficient production. Investments in research and development are essential for advancing reactor-based production technologies, optimizing target materials, and enhancing production yields to meet growing demand for Mo-99 worldwide.
In recent years, there has been growing interest and investment in cyclotron-based production methods for Mo-99, offering potential advantages in terms of flexibility, scalability, and safety. Cyclotron facilities require significant capital investment in infrastructure, particle accelerators, and target processing equipment. However, once operational, cyclotron-based production offers the flexibility to produce Mo-99 on-demand, reducing reliance on nuclear reactors and mitigating supply chain vulnerabilities. Investments in cyclotron technology drive innovation in radioisotope production, enabling the development of novel production routes and alternative isotopes beyond Mo-99, which could further diversify the market and enhance its resilience.
Beyond production facilities, infrastructure investment also encompasses distribution networks, quality control measures, and regulatory compliance to ensure the safe and efficient supply of Mo-99 to end-users globally. Investments in transportation infrastructure, such as specialized shipping containers and secure logistics networks, are critical for maintaining product integrity and minimizing radioactive decay during transit. Investments in quality assurance systems, supply chain tracking technologies, and regulatory compliance measures are essential for ensuring the safety, efficacy, and traceability of Mo-99 throughout the production and distribution process. Overall, infrastructure investment plays a vital role in supporting the growth and sustainability of the Global Molybdenum-99 Market, underpinning its critical role in nuclear medicine and diagnostic imaging worldwide.
Competitive Landscape Analysis
Key players in Global Molybdenum-99 Market include:
- IBA
- Sumitomo Corporation
- Advanced Cyclotron Systems, Inc.
- Siemens Healthineers
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Isotopic Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Molybdenum-99 Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Medical Imaging
- Nuclear Medicine
- Technetium-99m
- Restraints
- Supply Chain
- Production Challenges
- Technetium Shortage
- Opportunities
- Technological Innovation
- Supply Chain Optimization
- Infrastructure Investment
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Molybdenum-99 Market, By Isotopic Application, 2021 - 2031 (USD Million)
- Gamma Camera
- SPECT
- Global Molybdenum-99 Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Diagnostic Centers
- Global Molybdenum-99 Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia/New Zealand
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Molybdenum-99 Market, By Isotopic Application, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- IBA
- Sumitomo Corporation
- Advanced Cyclotron Systems, Inc.
- Siemens Healthineers
- Company Profiles
- Analyst Views
- Future Outlook of the Market